Research, cases and webinars in tricuspid interventions

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.

In this video you will learn:

• the theoretical implications of TR reduction for RV performance
• the clinical implications of TR reduction for biventricular performance

Implications of TTVI

Previous episode

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.
In this video you will learn about:

• the data supporting prognostic implications of interventional TR reduction
• the prognostic value of hemodynamic factors
• the importance of central venous congestion

1. Mortality and HF Hospitalization: Prognostic Benefit of Intervention...

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.

In this video you will learn:

• to recall the unique physiology of right ventricular function
• to understand the implications of RV pressure and volume load using the pressure-volume-loop framework
• to illustrate the...

Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure, starting in this first episode with the hemodynamic assessment.
In this video you will learn:

• to recognize the intricate relationship between symptoms and hemodynamics in (TR-related) right heart failure.
• to...

In this series of tutorials, Karl-Philipp Rommel (Leipzig, Germany) shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.

Take inspiration from the discussions on the case of a 78-year-old patient with HTN, HLD, and AF, presenting with symptomatic heart failure, or that of a 59-year-old female patient, former smoker, with HTN, DM, and persistent AF, who had been treated for breast carcinoma and post-chemotherapy...

Watch this session to enhance your knowledge on optimizing patients throughout the entire transcatheter tricuspid valve intervention process— from pre-procedure preparation to post-procedural care. Learn effective strategies for managing immediate and early complications, refine post-procedural treatment plans, and gain insights into future strategies aimed at further...

Join this session to delve into the incidence, outcomes, and survival of patients experiencing tricuspid regurgitation following lead placement. Explore contemporary outcomes of transcatheter edge-to-edge repair for lead-related tricuspid regurgitation, and gain insights into imaging assessment approaches for this condition.

This session explores the diverse phenotypes of tricuspid regurgitation patients, emphasizing the clinical implications and advocating for a multidisciplinary approach to assessment and treatment. It covers TR clinical courses, investigation pathways, and case scenarios, including atrial fibrillation, heart failure (preserved and reduced ejection fraction), pulmonary hypertension,...

Explore this tricuspid valve-focused session featuring analysis of four clinical cases: Ebstein anomaly, severe and torrential tricuspid regurgitations, and anterior flail-related torrential regurgitation. Gain insights into optimal treatment selection for each scenario, leveraging pre-procedural imaging for informed decision-making.

Explore insights from an 86-year-old female patient's case with TAVR since end-2022 who presented with permanent AF, moderate MR and TR regurgitation, and learn more about right heart catheterisation for patient selection, CT and CMR in tricuspid interventions, criteria for atrial secondary TR, and more!

Watch this session to explore the latest approaches in surgical and transcatheter tricuspid valve repair and replacement. Gain insights into the influence of right ventricular dysfunction and pulmonary hypertension on post-procedural outcomes, and understand the bleeding risks linked to oral anticoagulation in patients with tricuspid valve...

- When tricuspid regurgitation “begets” tricuspid regurgitation -

The aim of the b-RIGHT study was to assess the safety and performance of T-TEER using the TriClip (Abbott) in a contemporary, real-world setting...

Consult this session if you want to understand clinical scenarios associated with tricuspid regurgitation, to learn the state of the art in devices and indications to treat tricuspid regurgitation, and to deepen into the available evidence of outcomes of different therapies for tricuspid regurgitation.

In this video, members of the PCR Tricuspid Focus Group Nicole Karam and Ralph Stephan von Bardeleben, discuss the results of the Triluminate trial with David Adams and Paul Sorajja. Together they comment on the take-home messages presented during the ACC.23/WCC scientific sessions and how this...

In this video, members of the PCR Tricuspid Focus Group Nicole Karam and Ralph Stephan von Bardeleben talk with David Adams and Paul Sorajja about the first landmark trial in the field of tricuspid valve disease, Triluminate. Together they discuss the results presented during the ACC.23/WCC...

Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).

Population-based studies show a higher prevalence of significant TR in women and following that in published and ongoing trials on TTVI more women than men were enrolled. However, so far it has not been investigated whether such differences in epidemiology also would affect TTVI outcomes...

Although tricuspid regurgitation has for a long time been “the forgotten valve”, recently there has been a rising awareness of the disease with several important studies investigating its pathophysiology and treatment.